Drugs / J022X ST
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01948856 | Sep 2013 → Oct 2016 | respiratory tract infectious disorder | Pierre Fabre Laboratories | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | J022X ST | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01948856 ↗ |
| Route | Oral | “Oral administration” NCT01948856 ↗ |